What is Baze Labs?
Founded in 2014 by Philipp Schulte and Dr. Isam Haddad, Baze Labs provides a unique at-home blood-based nutritional testing kit. The service delivers high-quality, subscription-based supplements and tailored food recommendations by regularly measuring users' micronutrient levels. This data-driven approach aims to facilitate sustainable improvements in nutritional imbalances and overall health, positioning Baze Labs as a key player in the burgeoning field of personalized nutrition and preventative health.
How much funding has Baze Labs raised?
Baze Labs has raised a total of $6M across 1 funding round:
Series A
$6M
Series A (2019): $6M with participation from Nature's Way
Key Investors in Baze Labs
Nature's Way
Nature's Way is a well-established brand in the natural health and wellness industry, likely providing strategic backing to companies that align with their focus on natural supplements and health-conscious consumers.
What's next for Baze Labs?
The recent major strategic investment in Baze Labs signals a significant phase of expansion and development for the company. With a foundation built on scientific testing and personalized wellness, Baze Labs is poised to further innovate its offerings. This capital infusion is expected to fuel advancements in their diagnostic technology, enhance customer acquisition strategies, and potentially explore new market segments within the broader health and wellness industry. The company's focus on regular micronutrient analysis and tailored supplement delivery suggests a continued emphasis on long-term health management solutions.
See full Baze Labs company page
